Ebstein’s Anomaly Companies

ID: MRFR/MED/4178-HCR

105 Pages

Rahul Gotadki

October 2025

Ebstein's anomaly is a rare congenital heart defect that primarily affects the tricuspid valve, which separates the right atrium from the right ventricle. Companies involved in the healthcare and medical device industries may play a role in the development of treatments, devices, or therapies for individuals with Ebstein's anomaly.

Ebstein’s Anomaly Market Research Report- Forecast to 2035 Infographic

Summary Table of Contents Segmentation Download PDF

Top Industry Leaders in the Ebstein’s Anomaly Market

Ebstein’s Anomaly Companies

Latest Ebstein’s Anomaly Companies Update:

Mayo Clinic Established a multidisciplinary Ebstein's Anomaly Clinic to provide comprehensive care and support for patients.

American Heart Association (AHA) Launched an awareness campaign on congenital heart defects in September 2023, including information on Ebstein's Anomaly.

Mended Hearts Supports adults with congenital heart defects, including Ebstein's Anomaly, through patient education and advocacy programs.

List of Ebstein’s Anomaly Key companies in the market

Abbott Vascular

Boston Scientific Corporation

Cordis Corporation

Edwards Lifesciences

Ge Healthcare

Gore Medical

Medtronic, Inc.

Numed, Inc.

Siemens Healthcare

St. Jude Medical

Toshiba Corporation